Use of a tyrosine kinase inhibitor as neoadjuvant therapy for non-small cell lung cancer: A case report

We report here a 66-year-old woman diagnosed with bronchioloalveolar carcinoma of the right lung cT4N2M0. The patient was from the Philippines, had never smoked, and tested positive for an EGFR mutation. She received gefitinib as neoadjuvant therapy for two months and displayed a partial response. T...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: López-González, A., Almagro, E., Salas, C., Varela, A., Provencio, M.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2013
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3949555/
https://ncbi.nlm.nih.gov/pubmed/26029620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2013.02.002
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki